CVX vs STRO · P/E 17, rev $189.03B vs rev $62.0M
Chevron Corp (CVX) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CVX revenue for 2025-12-31 was $189.03B. Net income was $12.30B. Revenue was down 6.8% from 2024-12-31 to 2025-12-31. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CVX currently screens at market cap $250.20B and trailing P/E 16.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CVX and STRO stock pages for the full models.
Not investment advice.